Troyer D - Search Results

1

Obesity, adipokines, and prostate cancer in a prospective population-based study.

Baillargeon J, Platz EA, Rose DP, Pollock BH, Ankerst DP, Haffner S, Higgins B, Lokshin A, Troyer D, Hernandez J, Lynch S, Leach RJ, Thompson IM. Baillargeon J, et al. Among authors: troyer d. Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1331-5. doi: 10.1158/1055-9965.EPI-06-0082. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16835332

2

Genetic pattern of prostate cancer progression.

Saric T, Brkanac Z, Troyer DA, Padalecki SS, Sarosdy M, Williams K, Abadesco L, Leach RJ, O'Connell P. Saric T, et al. Among authors: troyer da. Int J Cancer. 1999 Apr 12;81(2):219-24. doi: 10.1002/(sici)1097-0215(19990412)81:2<219::aid-ijc9>3.0.co;2-3. Int J Cancer. 1999. PMID: 10188722

3

Identification of two distinct regions of allelic imbalance on chromosome 18Q in metastatic prostate cancer.

Padalecki SS, Troyer DA, Hansen MF, Saric T, Schneider BG, O'Connell P, Leach RJ. Padalecki SS, et al. Among authors: troyer da. Int J Cancer. 2000 Mar 1;85(5):654-8. doi: 10.1002/(sici)1097-0215(20000301)85:5<654::aid-ijc10>3.0.co;2-d. Int J Cancer. 2000. PMID: 10699945

4

Epididymal rhabdomyoma.

Matsunaga GS, Shepherd DL, Troyer DA, Thompson IM. Matsunaga GS, et al. Among authors: troyer da. J Urol. 2000 Jun;163(6):1876. J Urol. 2000. PMID: 10799212 No abstract available.

5

A reliable assessment of 8-oxo-2-deoxyguanosine levels in nuclear and mitochondrial DNA using the sodium iodide method to isolate DNA.

Hamilton ML, Guo Z, Fuller CD, Van Remmen H, Ward WF, Austad SN, Troyer DA, Thompson I, Richardson A. Hamilton ML, et al. Among authors: troyer da. Nucleic Acids Res. 2001 May 15;29(10):2117-26. doi: 10.1093/nar/29.10.2117. Nucleic Acids Res. 2001. PMID: 11353081 Free PMC article.

6

Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer.

Malik SN, Brattain M, Ghosh PM, Troyer DA, Prihoda T, Bedolla R, Kreisberg JI. Malik SN, et al. Clin Cancer Res. 2002 Apr;8(4):1168-71. Clin Cancer Res. 2002. PMID: 11948129

7

Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men.

Balic I, Graham ST, Troyer DA, Higgins BA, Pollock BH, Johnson-Pais TL, Thompson IM, Leach RJ. Balic I, et al. J Urol. 2002 Nov;168(5):2245-8. doi: 10.1016/S0022-5347(05)64364-9. J Urol. 2002. PMID: 12394768

8

Genetic fieldwork for hereditary prostate cancer studies.

Plaetke R, Thompson I, Sarosdy M, Harris JM, Troyer D, Arar NH. Plaetke R, et al. Among authors: troyer d. Urol Oncol. 2002 Jan-Feb;7(1):19-27. doi: 10.1016/s1078-1439(01)00132-6. Urol Oncol. 2002. PMID: 12474537

9

Risk perceptions among patients and their relatives regarding prostate cancer and its heredity.

Arar N, Thompson I, Sarosdy M, Harris M, Shepherd D, Troyer D, Plaetke R. Arar N, et al. Among authors: troyer d. Prostate Cancer Prostatic Dis. 2000 Nov;3(3):176-185. doi: 10.1038/sj.pcan.4500416. Prostate Cancer Prostatic Dis. 2000. PMID: 12497094

10

Challenges and opportunities to the design and implementation of chemoprevention trials for prostate cancer.

Thompson IM, Basler JA, Leach R, Troyer D, Klein E, Brawley O. Thompson IM, et al. Among authors: troyer d. Urol Oncol. 2003 Jan-Feb;21(1):73-8. doi: 10.1016/s1078-1439(02)00302-2. Urol Oncol. 2003. PMID: 12684131 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

307 results

Search Page

Filters